Benzodiazepine Derivatives As CCK2/Gastrin Receptor Antagonists
申请人:Trio Medicines Ltd
公开号:US20180215728A1
公开(公告)日:2018-08-02
The invention relates to benzodiazepine derivatives of formula (A) useful as CCK
2
/gastrin receptor antagonists, their preparation and their use in the treatment or prevention of disorders associated with CCK
2
/gastrin receptors, disorders caused by or associated with hypergastrinaemia, and gastric acid-related disorders.